Lipoxygenase products regulate nitric oxide and inducible nitric oxide synthase production in interleukin-1β stimulated vascular smooth muscle cells

Hypertension Research

Volumn 26, Issue 2, 2003, Pages 177-184

  Hashimoto, Tatsuo ^a   Kihara, Minoru ^a   Yokoyama, Keiko ^a   Fujita, Takayuki ^a   Kobayashi, Syun Ichi ^a   Matsushita, Kei ^a   Tamura, Kouichi ^a   Hirawa, Nobuhito ^a   Toya, Yoshiyuki ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Interleukin 1 ; Lipoxygenase; Nitric oxide; Phospholipase A2

Indexed keywords

2 (4 AMYLCINNAMIDO) 4 CHLOROBENZOIC ACID; HYDROXYICOSATETRAENOIC ACID; INDOMETACIN; INTERLEUKIN 1BETA; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; METABOLITE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

AMINOBENZOIC ACIDS; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; CINNAMATES; CYCLOOXYGENASE INHIBITORS; FLAVANONES; FLAVONOIDS; INTERLEUKIN-1; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NORDIHYDROGUAIARETIC ACID; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASES A; RATS; RATS, WISTAR;

EID: 0037300426     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.177     Document Type: Article

References (37)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-918.
3. Busse R, Mulsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275: 87-90.
4. Koide M, Kawahara Y, Tsuda T, Yokoyama M: Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 1993; 318: 213-217.
5. Yamamoto K, Ikeda U, Okada K, Saito T, Shimada K: Arginine vasopressin inhibits nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Hypertens Res 1997; 20: 209-216.
6. Chen H, Ikeda U, Shimpo M, Shimada K: Direct effects of statins on cells primarily involved in atherosclerosis. Hypertens Res 2000; 23: 187-192.
7. Doi M, Shichiri M, Katsuyama K, Marumo F, Hirata Y: Cytpline-activated p42/p44 MAP kinase is involved in inducible nitric oxide syntase gene expression independent from NF-κB activation in vascular smooth muscle cells. Hypertens Res 2000; 23: 659-667.
8. Behr D, Rupin A, Fabiani JN, Verbeuren TJ: Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 1999; 142: 335-344.
9. Buttery LD, Springall DR, Chester AH, et al: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75: 77-85.
10. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala S: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998; 18: 157-167.
11. Egashira K, Ni W, Inoue S, et al: Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions. Hypertens Res 2000; 23: 353-358.
12. Kuhlencordt PJ, Chen J, Han F, Astern J, Huang PL: Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001; 103: 3099-3104.
13. Natarajan R, Bai W, Rangarajan V, et al: Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol 1996; 169: 391-400.
14. Natarajan R, Rosdahl J, Gonzales N, Bai W: Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension 1997; 30: 873-879.
15. Natarajan R, Gonzales N, Lanting L, Nadler J: Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 1994; 23: I142-I147.
16. Parthasarathy S, Wieland E, Steinberg D: A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A 1989; 86: 1046-1050.
17. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, et al: Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A 1990; 87: 6959-6963.
18. Natarajan R, Gerrity RG, Gu JL, Lanting L, Thomas L, Nadler JL: Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 2002; 45: 125-133.
19. Cyrus T, Witztum JL, Rader DJ, et al: Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999; 103: 1597-1604.
20. Tamura K, Nyui N, Tamura N, et al: Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 1998; 273: 26487-26496.
21. Kihara M, Yabana M, Toya Y, et al: Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells. Kidney Int 1999; 55: 1277-1283.
22. Koide M, Kawahara Y, Tsuda T, Nakayama I, Yokoyama M: Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells. Hypertension 1994; 23: 145-148.
23. Hatta T, Nakata T, Harada S, et al: Lowering of blood pressure improves endothelial dysfunction by increase of nitric oxide production in hypertensive rats. Hypertens Res 2002; 25: 455-460.
24. Nyui N, Tamura K, Mizuno K, et al: Stretch-induced MAP kinase activation in cardiomyocytes of angiotensinogen-deficient mice. Biochem Biophys Res Commun 1997; 235: 36-41.
25. Imai Y, Kolb H, Burkart V: Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 1993; 197: 105-109.
26. Ryoyama K, Nomura T, Nakamura S: Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors. Cancer Immunol Immunother 1993; 37: 385-391.
27. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension 1998; 31: 218-224.
28. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M: Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells: synergism with the induction elicited by inflammatory cytokines. J Biol Chem 1993; 268: 24959-24966.
29. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
30. Fujita H, Saito F, Sawada T, Kushiro T, Yagi H, Kanmatsuse K: Lipoxygenase inhibition decreases neointimal formation following vascular injury. Atherosclerosis 1999; 147: 69-75.
31. Gu JL, Pei H, Thomas L, et al: Ribozyme-mediated inhibition of rat leukocyte-type 12-lipoxygenase prevents intimal hyperplasia in balloon-injured rat carotid arteries. Circulation 2001; 103: 1446-1452.
32. Shimpo M, Ikeda U, Maeda Y, Ohya K, Murakami Y, Shimada K: Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells. Hypertension 2000; 35: 1085-1091.
33. Chen YC, Shen SC, Chen LG, Lee TJF, Yang LL: Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001; 61: 1417-1427.
34. 2. J Biol Chem 1998; 273: 14411-14423.
35. 2 mediate IL-1beta-induced cAMP production in human vascular smooth muscle cells. Am J Physiol 1999; 276: H1369-H1378.
36. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994; 91: 12168-12172.
37. Nishio E, Watanabe Y: Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells. Life Sci 1999; 63: 429-439.